NCT00055393View on ClinicalTrials.gov

Bupropion in the Treatment of Pathological Gambling

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

May 31, 2005

Study Completion Date

April 30, 2006

Conditions
Pathological Gambling
Interventions
DRUG

Bupropion

18 subjects in this randomly controlled double blind study received bupropion.

DRUG

Placebo

21 subjects received Placebo.

Trial Locations (1)

52242

Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Iowa

OTHER

NCT00055393 - Bupropion in the Treatment of Pathological Gambling | Biotech Hunter | Biotech Hunter